Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial.

By B. Olsson. The Lancet, 2003

860 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Internal Medicine, Nutrition and Dietetics

View Paper: https://www.semanticscholar.org/paper/4b43ff338f98af87703b954f1dc9b3b19d382e84